Deletion of Col15a1 Modulates the Tumour Extracellular Matrix and Leads to Increased Tumour Growth in the MMTV-PyMT Mouse Mammary Carcinoma Model
Authors:
- Guillermo Martínez-NietoGMGuillermo Martínez-Nieto
- Ritva HeljasvaaraRHRitva Heljasvaara
- Anne HeikkinenAHAnne Heikkinen
- Hanne-Kaisa KaskiHKHanne-Kaisa Kaski
- Raman DevarajanRDRaman Devarajan
- Otto RinneOROtto Rinne
- Charlotta HenrikssonCHCharlotta Henriksson
- Emmi ThomsonETEmmi Thomson
- Camilla von HertzenCHCamilla von Hertzen
- Ilkka MiinalainenIMIlkka Miinalainen
- Heli RuotsalainenHRHeli Ruotsalainen
- Taina PihlajaniemiTPTaina Pihlajaniemi
Open Access
- 15 September 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (18) , 9978
Abstract
Basement membrane (BM) zone-associated collagen XV (ColXV) has been shown to suppress the malignancy of tumour cells, and its restin domain can inhibit angiogenesis. In human breast cancer, as well as in many other human carcinomas, ColXV is lost from the epithelial BM zone prior to tumour invasion. Here, we addressed the roles of ColXV in breast carcinogenesis using the transgenic MMTV-PyMT mouse mammary carcinoma model. We show here for the first time that the inactivation of Col15a1 in mice leads to changes in the fibrillar tumour matrix and to increased mammary tumour growth. ColXV is expressed by myoepithelial and endothelial cells in mammary tumours and is lost from the ductal BM along with the loss of the myoepithelial layer during cancer progression while persisting in blood vessels and capillaries, even in invasive tumours. However, despite the absence of anti-angiogenic restin domain, neovascularisation was reduced rather than increased in the ColXV-deficient mammary tumours compared to controls. We also show that, in robust tumour cell transplantation models or in a chemical-induced fibrosarcoma model, the inactivation of Col15a1 does not affect tumour growth or angiogenesis. In conclusion, our results support the proposed tumour suppressor function of ColXV in mammary carcinogenesis and reveal diverse roles of this collagen in different cancer types.Keywords
Funding Information
- FP7 People: Marie-Curie Actions (316610)
- Research Council of Finland (308867, 284065, 128259)
- Sigrid Juséliuksen Säätiö (-)
- Jane ja Aatos Erkon Säätiö (-)
- Emil Aaltosen Säätiö (-)
- Suomen Kulttuurirahasto (-)
This publication has 46 references indexed in Scilit:
- Collagen XV Inhibits Epithelial to Mesenchymal Transition in Pancreatic Adenocarcinoma CellsPLOS ONE, 2013
- Tumor suppression by collagen XV is independent of the restin domainMatrix Biology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Collagen XV Is Necessary for Modeling of the Extracellular Matrix and Its Deficiency Predisposes to CardiomyopathyCirculation Research, 2010
- Recombinant Human Collagen XV Regulates Cell Adhesion and MigrationJournal of Biological Chemistry, 2010
- Complete Suppression of Tumor Formation by High Levels of Basement Membrane CollagenMolecular Cancer Research, 2007
- Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and NeoplasiaJournal of Mammary Gland Biology and Neoplasia, 2005
- Proteoglycan-Collagen XV in Human Tissues Is Seen Linking Banded Collagen Fibers Subjacent to the Basement MembraneJournal of Histochemistry & Cytochemistry, 2005
- Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activityJournal of Molecular Biology, 2000
- Antiangiogenic Activity of Restin, NC10 Domain of Human Collagen XV: Comparison to EndostatinBiochemical and Biophysical Research Communications, 1999